Viewing Study NCT07132502


Ignite Creation Date: 2025-12-25 @ 4:05 AM
Ignite Modification Date: 2025-12-31 @ 2:06 PM
Study NCT ID: NCT07132502
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-08-20
First Post: 2025-07-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Treatment Intermittent Periods Based on ctDNA-MRD(Circulating Tumor DNA-minimal Residual Disease) Status in Advanced HER2-Positive Breast Cancer
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2025-08-25
Start Date Type: ESTIMATED
Primary Completion Date: 2027-07-08
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-07-15
Completion Date Type: ESTIMATED
First Submit Date: 2025-07-06
First Submit QC Date: None
Study First Post Date: 2025-08-20
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-08-17
Last Update Post Date: 2025-08-20
Last Update Post Date Type: ACTUAL